Gestational trophoblastic disease
Placental site nodule
Reviewers: Mandolin Ziadie, M.D. (see Reviewers page)
Revised: 16 November 2011, last major update October 2011
Copyright: (c) 2003-2011, PathologyOutlines.com, Inc.
● Nodule composed of benign cells similar to those in the chorion lavae; often an incidental finding on endometrial biopsies / endocervical curettage
● Remnant of implantation site that failed to involute; may be identified many years after pregnancy
● Women may complain of abnormal bleeding
● No treatment required
● Yellow-tan nodular or plaquelike lesion(s) at placental site, up to 1 cm, often in endometrial curettings
● Well-circumscribed, extensively hyalinized and paucicellular, oval or plaquelike nodule(s)
● Cells are chorionic-type intermediate trophoblast cells with abundant eosinophilic, amphophilic or clear (glycogen-rich) cytoplasm, irregular / degenerative appearing nuclei
● No/rare mitotic figures (Am J Surg Pathol 1990;14:1001)
● May contain mallory bodies (Arch Pathol Lab Med 1993;117:547)
● CK18, EMA, HLA-G (Am J Surg Pathol 2002;26:914), inhibin-alpha (strong), Ki-67 (3-10%) and PLAP
● hCG, hPL (may be weak) and Mel-CAM (may be weak)
● Placental site trophoblastic tumor: larger, not well circumscribed, no extensive hyalinization, mitotically active, strong staining for hPL and PLAP and weak staining for PLAP
● Squamous cell carcinoma of cervix: necrosis, mitotically active, CK18 and inhibin-alpha negative (Hum Pathol 1999;30:687)
● Epithelioid trophoblastic tumor
End of Placenta > Gestational trophoblastic disease > Placental site nodule
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).